This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Quest Diagnostics Inc (DGX)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 7.49B 7.43B 7.15B 7.38B
Cost of Sales 4.43B 4.42B 4.12B 4.15B
Gross Operating Profit 3.06B 3.02B 3.02B 3.23B
Selling, General, and Administrative Expenses 1.68B 1.73B 1.70B 1.75B
Research & Development n.a. 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 1.38B 1.29B 1.32B 1.48B
Depreciation & Amortization 304.00M 314.00M 283.00M 286.60M
Interest Income n.a. 3.00M 3.00M 3.00M
Other Income - Net 214.00M 4.00M 482.00M 6.66M
Special Income / Charges -11.00M 7.00M -36.00M 2.88M
Total Income Before Interest Expenses (EBIT) 1.28B 1.02B 1.51B 1.24B
Interest Expense 153.00M 167.00M 162.00M 167.69M
Pre-Tax Income 1.13B 849.00M 1.35B 1.07B
Income Taxes 373.00M 262.00M 500.00M 401.90M
Minority Interest 44.00M 36.00M 34.00M 36.41M
Net Income From Continuing Operations 753.00M 587.00M 848.00M 666.50M
Net Income From Discontinued Operations 0.00 5.00M 35.00M -74.36M
Net Income From Total Operations 753.00M 592.00M 883.00M 592.13M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 709.00M 556.00M 849.00M 555.72M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
764.00M 580.00M 884.00M 663.62M
Preferred Dividends
Net Income Available To Common 0.00 587.00M 848.00M 666.50M
Basic EPS from Continuing Ops. 4.92 3.80 5.35 3.96
Basic EPS from Discontinued Ops. 0.00 0.03 0.23 -0.47
Basic EPS from Total Operations 4.92 3.83 5.58 3.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.92 3.83 5.58 3.49
Basic Normalized Net Income/Share 4.99 3.75 5.58 3.94
EPS fr Continuing Ops. 4.87 3.78 5.31 3.92
EPS fr Discontinued Ops 0.00 0.03 0.23 -0.47
EPS fr Total Ops. 4.87 3.81 5.54 3.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.01
EPS, Total 4.87 3.81 5.54 3.46
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.94 3.73 5.54 3.90
Dividends Paid per Share 1.47 1.29 1.20 0.68
DGX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

DGX Quest Diagnostics Inc

Chart of DGX

Analysts Ratings for DGX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 15 15 15 15
Moderate Sell 1 1 1 0
Strong Sell 1 1 1 1
GET DGX ANALYST REPORT

DGX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs